Platelets release excessive amounts of transforming growth factor-β1 (TGF-β1), which induces the down-regulation of C-type lectin-like NKG2D receptors, resulting in a decrease in the anti-tumor activity of NK cells 25. The gene discussed is TGFB1; the disease is neoplasm.